Ex parte NOJIRI et al. - Page 8




          Appeal No. 95-3320                                                          
          Application 07/974,510                                                      
          finding of motivation is clearly erroneous for two reasons.                 
          First, the evidence of record establishes that persons having               
          ordinary skill in the art would not have looked to the egg                  
          yolk of domestic hens for “an alternative source” for the                   
          mammalian antibody utilized in the prior art because the serum              
          antibodies derived from Widder’s mammalian blood immunized                  
          using human hair as an antigen are distinct from yolk                       
          antibodies derived from an egg of a domestic fowl immunized                 
          using human hair as an antigen.  Second, the cited prior art                
          does not recognize any inconvenience associated with the                    
          removal of blood from chickens immunized with human hair as an              
          antigen.                                                                    
               There must be a reason or suggestion in the art for                    
               selecting the procedure used, other than the knowledge                 
               learned from the applicant’s disclosure.                               
          In re Dow Chem. Co., at 473, 5 USPQ2d at 1532.  For the                     
          reasons stated, we reverse the examiner’s rejection.  “Both                 
          the                                                                         
          suggestion and the expectation of success must be founded in                
          the prior art disclosure, not in the applicant’s disclosure.”               
          Id.                                                                         
          at 473, 5 USPQ2d at 1531.                                                   
                                     Conclusion                                       
                                        - 8 -                                         





Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007